en · de · es
lab-handbook.peptides9000.com › Info › Epitalon Background And Nomenclature — Field Notes

Epitalon Background And Nomenclature — Field Notes

By Editorial Desk · published 2025-07-28 · last reviewed 2025-08-28 · Info

Khavinson is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2025-08-28. Where a claim depends on a specific study, the study is described rather than over-claimed.

Epitalon Background and Nomenclature

Laboratory work has examined effects on telomerase activity in cultured cells, on melatonin rhythms in animals, and on markers of oxidative stress. Some experiments report measurable changes while others show none, and the reported findings rest largely on small studies. The absence of large independent trials means the generality of these results is unresolved rather than settled. Review articles occasionally apply the label geroprotector, a term that reflects a research hypothesis about ageing rather than an established clinical finding.

Epitalon is the common name for a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, usually abbreviated AEDG. All four residues are proteinogenic amino acids, and the free peptide has a calculated mass near 390 grams per mole. Because the chain is short and carries no modifications, it is assembled readily by solid-phase synthesis and is distributed mainly as a freeze-dried solid for laboratory work. Catalogue listings use the spellings epitalon, epithalone, and simply AEDG, and the three refer to the same sequence.

The compound is generally presented as a synthetic fragment of epithalamin, a pineal gland extract investigated in the former Soviet Union from the 1970s onward. Vladimir Khavinson and colleagues in Saint Petersburg developed short peptides modelled on such extracts, and epitalon became the most widely cited of those sequences. Most primary reports appeared in Russian-language journals or in proceedings with limited international circulation. Independent replication in laboratories outside that network remains sparse, and much repeated secondary material traces back to a small number of originating groups.

Research Claims and Evidence Status

Animal and clinical reports appear mainly in Russian-language journals from the 1990s and 2000s, covering endpoints such as melatonin rhythm, lifespan in aged rodents, and retinal function. Many of these papers involve small groups, lack blinding or placebo comparison, and are difficult to retrieve through indexed databases. Review articles published in English generally summarise the claims without reanalysing the underlying data. Because no large randomised trial exists, the clinical importance of these reported effects stays unresolved and is properly described as an open question.

No national medicines regulator has approved epitalon as a therapeutic product. It is generally distributed as a research chemical, and in some jurisdictions selling peptides for human consumption without approval is restricted or prohibited. Certificates of analysis accompanying commercial material vary in which tests are performed, and independent verification of identity and purity is uncommon. Statements about anti-ageing or disease-prevention benefits on vendor pages are marketing claims rather than regulatory findings, a distinction that shapes how the compound is discussed in scientific and popular sources alike.

Epitalon at a glance

PropertyValueNotes
Molecular formulaC14H22N4O9Computed for the free acid of Ala-Glu-Asp-Gly
Molecular massAbout 390.35 g/molFree peptide; salt forms shift the value
AppearanceWhite to off-white solidTypical of short peptides after freeze-drying
Solubility classFreely soluble in waterAqueous buffers are also commonly used
Common synonymsEpitalon, epithalone, AEDGAEDG is the single-letter sequence

Structure, Naming and Discovery

Residue composition is the property that most cleanly separates verified material from mislabelled samples. Alanine, glutamate, aspartate and glycine appear in that order from the N-terminus, and the two acidic residues sit in the middle of the chain. Because the peptide is short, it can be produced by solid-phase synthesis and characterised by mass spectrometry without ambiguity. Any reported sample whose measured mass departs substantially from 390 daltons is a different compound or a degraded mixture rather than epitalon.

Epitalon is a synthetic tetrapeptide whose four residues are alanine, glutamate, aspartate and glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9 and its monoisotopic mass is near 390.35 daltons. The peptide carries two acidic side chains, so it is neutral to negatively charged in most aqueous buffers. Published reference summaries usually list it under both spellings, epitalon and epithalon, and treat the two names as the same material.

Related pages on this site

Epitalon in Research Literature and Handling

Regulatory status varies by country and is not harmonized. Epitalon is not an approved drug in major Western jurisdictions. In some countries it is sold as a research chemical, and in others it has appeared in products marketed for other categories. This inconsistent status means that purity, labeling accuracy, and documentation differ widely between suppliers, and verification of identity and purity through independent analysis is the usual way buyers assess a given lot.

Epitalon appears in the literature primarily through a small number of research groups, most of them associated with the St. Petersburg Institute of Bioregulation and Gerontology. Publications describe cell culture experiments, animal studies, and a limited number of small human studies. Independent replication outside this network is sparse. As a result, reviews of the topic usually separate descriptive reports of observed effects from the question of whether those effects generalize, and they note the difficulty of comparing studies that use different preparations and endpoints.

Supporting material

=== Experimental application === As described in the applications section, spectrophotometry can be used in both qualitative and quantitative analysis of DNA, RNA, and proteins. Qualitative analysis can be used and spectrophotometers are used to record spectra of compounds by scanning broad wavelength regions to determine the absorbance properties (the intensity of the color) of the compound at each wavelength. One experiment that can demonstrate the various uses that visible spectrophotometry can have is the separation of β-galactosidase from a mixture of various proteins. Largely, spectrophotometry is best used to help quantify the amount of purification your sample has undergone relative to total protein concentration. By running an affinity chromatography, B-Galactosidase can be isolated and tested by reacting collected samples with Ortho-Nitrophenyl-β-galactoside (ONPG) and determining if the sample turns yellow. Following this testing the sample at 420 nm for specific interaction with ONPG and at 595 for a Bradford Assay the amount of purification can be assessed quantitatively. In addition to this spectrophotometry can be used in tandem with other techniques such as SDS-Page electrophoresis in order to purify and isolate various protein samples.

Physical exercising activities such as homeopathy2, walking and swimming of the dog are suggested under behavioral management in treating diabetes because it results in tissue preservation. Dietary management in food service is also essential in preventing diabetes attack. A dietary management may include low fat content foods, complex carbohydrates that aid in slowing down glucose absorption, protein and fiber.

=== Reasons for the development of multicellularity === Despite the fact that prokaryotic cells contained the building blocks required for multicellularity to arise, this transition did not occur for around 1500 million years after the origins of the first eukaryotic cell. Scientists have proposed two major theories for the reason that multicellularity arose so late after the appearance of life on Earth.

Sperm competition has caused the human penis to evolve in length and size for sperm retention and displacement. To achieve this, the penis must be of sufficient length to reach any rival sperm and to maximally fill the vagina. In order to ensure that the female retains the male's sperm, the adaptations of increased length of the human penis have occurred so that the ejaculate is placed close to the female cervix. This is achieved when complete penetration occurs and the penis pushes against the cervix. These adaptations have occurred in order to release and retain sperm to the highest point of the vaginal tract. As a result, this adaptation also leaves the sperm less vulnerable to sperm displacement and semen loss. Another reason for this adaptation is that, due to the nature of the human posture, gravity creates vulnerability for semen loss. Therefore, a long penis, which places the ejaculate deep in the vaginal tract, could reduce the loss of semen. Another evolutionary theory of penis size is female mate choice and its associations with social judgements in modern-day society. A study which illustrates female mate choice as an influence on penis size presented females with life-size, rotatable, computer generated males. These varied in height, body shape and flaccid penis size, with these aspects being examples of masculinity. Female ratings of attractiveness for each male revealed that larger penises were associated with higher attractiveness ratings.

Sources: en.wikipedia.org

Supporting material

A Marvel-themed orchestra performance of an extended version of Brian Tyler's Marvel Studios theme and Alan Silvestri's theme from The Avengers took place during China's Bilibili New Year's Gala on December 31, 2020, to promote the 2021 Marvel Studios film releases. A special titled Marvel Studios' 2021 Disney+ Day Special, which looked at the future of the MCU on Disney+, was released on the service on November 12, 2021, as part of its "Disney+ Day" celebration.

== Transmutation of technetium to stable ruthenium-100 == Technetium (Tc) can be completely transformed into ruthenium-100 by coating the inner cladding of fuel rods with Tc. This works with conventional pressurized water reactors and does not require specialized transmutation facilities. An alternative disposal method, transmutation, has been demonstrated at CERN and NIIAR for technetium-99. This transmutation process bombards the technetium (99Tc as a metal target) with neutrons, forming the short-lived 100Tc (half-life 16 seconds), which decays by beta decay to stable ruthenium (100Ru). Given the relatively high market value of ruthenium and the particularly undesirable properties of technetium, this type of nuclear transmutation appears particularly promising.

== Adverse effects == Common side effects include low blood sugar, problems at the site of injection, itchiness, and weight gain. Serious side effects include low blood potassium. As of 2012, tentative evidence shows no association between insulin glargine and cancer. Previous studies had raised concerns. When comparing insulin glargine to NPH insulin, insulin detemir or insulin degludec, no significant adverse effects were found in the management of type 1 diabetes in either adults or children in periods of six months or longer.

== Arrival of the Russian army in Abkhazia == On 3 August 2008, Ogoniok reported that journalist had witnessed Russian military convoy entering Abkhazia on the Russo-Abkhaz border in late July 2008. There had been non-stop movement of the railway echelons in Abkhazia several weeks earlier and that between forty-five and fifty railway cars with tanks had entered the Gali district on the Abkhaz-Georgian border. It also reported that the quantity of armaments and ammunition in Abkhazia was enough to wage a conflict for several years. An unnamed Russian colonel from the peacekeeping forces told journalist that he was expecting that "something will happen." Journalist witnessed that "special-looking" men were crossing the Russo-Abkhaz border. Abkhaz leader Sergei Bagapsh said to journalist: "We are ready for the war, but I am not about to tell the whole world in detail how we have prepared ourselves." Abkhaz leader also commented on the Georgian presence in the Kodori Valley, "You know, we can not indefinitely tolerate their antics in our backyard. It is time to put things in order there." Although Bagapsh had hinted at something, he added that the Abkhaz would never shoot first towards Georgia. In January 2015, resident of Sochi, Oksana Sevastidi, was arrested for treason. She had sent a SMS to the Georgian friend in 2008 in which she reported on the movement of the Russian troops by the railroad to the Abkhaz border before the war. In March 2015, the Supreme Court of Russia reviewed a case of a woman from Sochi, who was accused of treason.

=== The Scar Free Foundation === In 2016, The Healing Foundation officially rebranded as The Scar Free Foundation. This change was made following a detailed assessment of previous work and future priorities with clinicians, scientists, Partner Member Organisations, and people with lived experience of scarring. The charity pivoted to focus exclusively on wound healing and scarring conditions. A new Research Strategy was developed by a panel chaired by Professor Sir John Iredale. Brendan Eley was succeeded as CEO by Richard Nugee in April 2023.

Sources: en.wikipedia.org

Frequently asked questions

What is epitalon made of?

It is a four-amino-acid peptide with the sequence alanine-glutamate-aspartate-glycine. The chain is unmodified and contains only standard proteinogenic residues, which makes it straightforward to produce by solid-phase synthesis and to characterise by standard peptide methods.

Why do two spellings appear in the literature?

Epitalon and epithalon both circulate, and the difference reflects transliteration of a name coined in Russian-language publications. Reference to the extract it derives from, epithalamin, explains the shared stem. Databases and suppliers are inconsistent, so a search for one spelling alone may miss relevant entries.

Is epitalon the same substance as epithalamin?

No. Epithalamin is a multi-component preparation obtained from pineal tissue, and its exact composition is not fully characterised. Epitalon is a single defined tetrapeptide described as a short synthetic counterpart of that extract, so the two are related in origin but not interchangeable in identity.

Has epitalon been studied in people?

Small studies with human participants have been reported, chiefly in Russian-language journals, but they are limited in size and design. No large randomised controlled trial with published results is available.

Network